Reducing Cancer Drug Cost: 3-Year Analysis of Automated Dose Rounding in Electronic Health Records
- 1 March 2025
- journal article
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 21 (3) , 400-407
Abstract
PURPOSE: Globally, cancer drug expenditure exceeds $185 in US dollars (USD) billion, with the United States contributing $75 (USD) billion. Many cancer drug doses are calculated on the basis of body weight or body surface area, which often results in leftover drug in partially used single-dose vials (SDVs). The cost of wasted drug is a huge financial burden on the US health care system. We evaluated the cost savings resulting from the reduction of SDV wastage, achieved through the implementation of automated dose rounding rules in electronic health records (EHRs). METHODS: Mayo Clinic implemented automated dose rounding rules within the EHR. These rules were designed to round calculated doses to the nearest SDV if the vial size closely matched the original calculated dose, within a 10% threshold. We assessed doses administered between January 2019 and December 2021, and computed cost-savings, waste reduction, and cost of waste for chemotherapy drugs. RESULTS: In 3 years, 36.1% of doses were rounded down, 35.8% were rounded up, and 28.1% were exact doses. By rounding doses down to a vial size, we achieved cost-savings of $39.75 (USD) million and prevented 62,065 SDV of cancer drugs from going to waste. By rounding doses up, we avoided wasting $9.95 (USD) million worth of drugs. However, there were still instances where the rounding fell outside of the 10%, resulting in wasted drugs worth $25 (USD) million. CONCLUSION: The substantial burden imposed on patients and the US health care system because of cancer drug wastage is of significant concern. Although the automated dose rounding system represents a partial solution for this issue, a comprehensive approach involves the imperative development of policy and legislative solutions to effectively mitigate the challenges associated with cancer drug waste.Keywords
This publication has 13 references indexed in Scilit:
- Opportunity Strikes for Reducing Cancer Drug Waste: Bortezomib as an Example of Vial Mis-Sizing in OncologyJCO Oncology Practice, 2024
- Decreasing drug waste, reducing drug costs, and improving workflow efficiency through the implementation of automated chemotherapy dose rounding rules in the electronic health record systemAmerican Journal of Health-System Pharmacy, 2021
- Medical Care Costs Associated with Cancer Survivorship in the United StatesCancer Epidemiology, Biomarkers & Prevention, 2020
- Financial toxicity of cancer treatment: Moving the discussion from acknowledgement of the problem to identifying solutionseClinicalMedicine, 2020
- Implementation of Drug Vial Optimization to Reduce Drug WasteOncology Issues, 2019
- Dose Rounding of Biologic and Cytotoxic Anticancer Agents: A Position Statement of the Hematology/Oncology Pharmacy AssociationJournal of Oncology Practice, 2018
- The high price of anticancer drugs: origins, implications, barriers, solutionsNature Reviews Clinical Oncology, 2017
- Overspending driven by oversized single dose vials of cancer drugsBMJ, 2016
- Chemotherapy Dosing Part I: Scientific Basis for Current Practice and Use of Body Surface AreaClinical Oncology, 2007
- Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.Journal of Clinical Oncology, 1996